Evidence map›Paper›PMID 31068932›Full record

ReviewFrontiers in immunology2019

Emerging Role of Lymphocyte Antigen-6 Family of Genes in Cancer and Immune Cells.

Geeta Upadhyay

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 148 citations in OpenAlex.

  1. Article
  2. Inherited Susceptibility to Urinary Tract Infections from Kidney Papilla to Bladder.medRxiv : the preprint server for health sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Ly6/uPAR Protein fromMarine drugs · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Geeta UpadhyayDepartment of Pathology, John P. Murtha Cancer Center, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
Uniformed Services University of the Health Sciences · US

Funding

Role of Ly6K in TGF-beta and immune escape pathways of triple negative breast cancerR01CA227694 · NCI · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI Geeta Upadhyay · 2018 to 2026
$2.4M
NCI NIH HHS R01 CA227694
6 · The paper itself

Abstract

Stem Cell Antigen-1 (

Indexed as

Disease SusceptibilityMultigene FamilyAnimalsAtaxin-1Gene Expression Regulation, NeoplasticHumansLymphocytesMiceNeoplasmsOrgan SpecificityAtaxin-1ATXN1 protein, humanImmuneLY6DLY6ELY6HLY6KOncologyTGF-β

Identifiers

PMID31068932
PMCPMC6491625
OpenAlexW2934533555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.